Abstract
There is a considerable degree of allelic variation in human populations. Some variants have deleterious consequences for the individual possessing them, and selective forces strongly oppose their spread in populations. Other genetic variants may have been of selective advantage in the past and consequently their frequencies have increased in the population. However, due to possible changes in environment, these variants may now be neutral or slightly disadvantageous for the individual. Such variants may provide the genetic basis for the common metabolic diseases such as type II diabetes mellitus and the hyperlipidaemias. They would be expected to occur at the same frequency as the disease (at frequencies greater than 1–2% in the population) and would therefore fall within the definition of a genetic polymorphism.1
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D.J. Galton, “Molecular Genetics of Common Metabolic Disease” publ. E. Arnold, London (1968).
P.S. Rotwein, J. Chirgwin, M. Province, W.C. Knowler, D.J. Pettit, B. Cordel, H.M. Goodman and M.A. Permutt, The 5′ flanking region of the human insulin gene: a genetic marker for non-insulin dependent diabetes. N. Engl. J. Med. 308:65 (1983).
N.I. Jowett, L.G. Williams, G.A. Hitman and D.J. Galton Diabetic hypertriglyceridaemia and a related 5′ flanking polymorphism of the human insulin gene. Br.Med.J. 288:96 (1984).
A. Rees, J. Stocks, C.C. Shoulders, D.J. Galton and F.E. Baralle, DNA polymorphism adjacent to the human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet i: 444 (1983).
T.J. Knott, R.L. Eddy, M.E. Robertson, L.M. Priestley, J. Scott and T.B. Shows, Chromosome localization of the human apoprotein C-1 gene and of a polymorphic apoprotein A-II gene. Biochem. Biophys. Res. Comm. 125:299 (1984).
J. Scott, L.M. Priestley, T.J. Knott, M.E. Robertson,, G. Kostner, G.J. Miller and N.E. Miller, High density lipoprotein composition is altered by a common DNA polymorphism adjacent to the apoprotein A-II gene in Man. Lancet i:771 (1985).
L.G. Williams, N.I. Jowett, M.A. Vella, S. Humphries and D.J. Galton, Allelic variation adjacent to the human insulin an apoprotein C-II genes in different ethnic groups. Human Genetics (in press).
A. Rees, J. Stocks, C.R. Sharpe, M.A. Vella, C.C. Shoulders, J. Katz, N.I. Jowett, F.E. Baralle and D.J. Galton, DNA polymorphism in the apo A1/CIII gene cluster: association with hypertriglyceridaemia. J. Clin. Invest. (in press).
S. Humphries, N.I. Jowett, L.G. Williams, A. Rees, M.A. Vella, O. Myklebost, A Lydon, M. Seed, D.J. Galton, R. Williamson, A DNA polymorphism adjacent to the human apolipoprotein C-II gene. Molec. Biol and Med. i:463 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ferns, G.A.A., Shelley, S.C., Rees, A., Stocks, J., Galton, D.J. (1986). An Apoprotein AII Gene Polymorphism and Hyperlipidaemia. In: Sirtori, C.R., Nichols, A.V., Franceschini, G. (eds) Human Apolipoprotein Mutants. NATO ASI Series, vol 112. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9474-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9474-1_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9476-5
Online ISBN: 978-1-4615-9474-1
eBook Packages: Springer Book Archive